Technological advancements such as single-use bioreactor technology and development of personalized medicines involving several clinical trials and bioprocesses will propel market growth. Concerns related to disposables and leachable coupled with low capacity of single-use bioreactors will hinder bioreactor market growth over the coming years.

Bacterial cells market should grow at lucrative rate due to rising demand for advanced antibiotics, increasing prevalence of food borne diseases and growth of food microbiology sector. Rising adoption of immobilized bacterial bioreactors in small manufacturing plant and commercial laboratories will fuel business growth.

Contract manufacturing organizations (CMO's) market will exhibit lucrative growth over the forecast period due to rising number of contract manufacturing organizations and growing demand for biopharmaceuticals. Rising trend in pharmaceutical industry towards outsourcing clinical trials and other such functions to CMO's to reduce regulatory burden and cost will favor industry growth.

U.S. bioreactors market should grow at a significant CAGR over the forecast period. Increasing investment in R&D pertaining to biopharmaceuticals and growing adoption of single-use products will drive U.S. bioreactors market. Rising demand for personalized medicines and technological advancements in products will positively impact market growth.

High growth of biotechnology industry along with initiation of programs such as 'The National Biotechnology Program' will drive Brazil bioreactors market over the forecast period. Strategic collaboration between pharmaceutical companies and research organizations, universities will favor business growth.

South Africa bioreactors market will be driven by rising prevalence of chronic diseases stimulating demand for personalized medicines, growing adoption of biopharmaceutical products and increased investment for healthcare infrastructure development. Favorable government policies to support growth of biotechnology industry will favor regional growth.

Few notable industry players include GE Healthcare, Sartorius, Thermo Fisher Scientific, Eppendorf, and Merck Millipore. Strategic alliances, merger and acquisitions are key strategies followed by market players to strengthen their product portfolio and position in the market.